SARM1 and frontotemporal dementia: Sarm1 deletion was beneficial in the TDP-43Q331K model of amyotrophic lateral sclerosis-frontotemporal dementia [29], but had no significant impact on axonal loss or clinical course of mutant SOD1 model of amyotrophic lateral sclerosis [30].